Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ncgc00167966-01
2. Dsstox_cid_26750
3. Dsstox_rid_81875
4. Dsstox_gsid_46750
5. Chembl1874250
6. Dtxsid20858848
7. Tox21_112595
8. Akos015960603
9. Ac-11740
10. Ac-31947
11. Cas-9004-61-9
12. (4xi)-alpha-d-xylo-hexopyranuronosyl-(1->3)-(3xi)-2-(acetylamino)-2-deoxy-beta-d-ribo-hexopyranosyl-(1->4)-(5xi)-beta-d-xylo-hexopyranuronosyl-(1->3)-2-(acetylamino)-2-deoxy-d-glucopyranose
1. Hyaluronan
Molecular Weight | 776.6 g/mol |
---|---|
Molecular Formula | C28H44N2O23 |
XLogP3 | -7.4 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 23 |
Rotatable Bond Count | 12 |
Exact Mass | 776.23348565 g/mol |
Monoisotopic Mass | 776.23348565 g/mol |
Topological Polar Surface Area | 400 Ų |
Heavy Atom Count | 53 |
Formal Charge | 0 |
Complexity | 1300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 16 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
Registration Number : 302MF10032
Registrant's Address : Shibuya 1-4-13, Shibuya-ku, Tokyo
Initial Date of Registration : 2020-02-27
Latest Date of Registration :
Available Reg Filing : CN |
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA
Helping its partners for Enzymes, Diagnostics and other products through its cutting edge Fermentation technology.
Registration Number : 217MF10551
Registrant's Address : 250 Noda, Noda City, Chiba Prefecture
Initial Date of Registration : 2005-09-09
Latest Date of Registration :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15408
Submission : 2001-04-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15901
Submission : 2002-03-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15408
Submission : 2001-04-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15901
Submission : 2002-03-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11593
Submission : 1995-07-20
Status : Inactive
Type : II
Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
Registration Number : 302MF10032
Registrant's Address : Shibuya 1-4-13, Shibuya-ku, Tokyo
Initial Date of Registration : 2020-02-27
Latest Date of Registration : 2020-02-27
Helping its partners for Enzymes, Diagnostics and other products through its cutting edge Fermentation technology.
Registration Number : 217MF10551
Registrant's Address : 250 Noda, Noda City, Chiba Prefecture
Initial Date of Registration : 2005-09-09
Latest Date of Registration : 2009-09-24
Registration Number : 218MF10489
Registrant's Address : 2-1-1 Muromachi, Nihonbashi, Chuo-ku, Tokyo
Initial Date of Registration : 2006-05-15
Latest Date of Registration : 2016-12-05
Registration Number : 223MF10130
Registrant's Address : 250 Noda, Noda City, Chiba Prefecture
Initial Date of Registration : 2011-08-19
Latest Date of Registration : 2011-08-19
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Italy
Brand Name : JONEXA TROPHIC
Dosage Form : Pre-Filled Syringe
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Packaging :
Regulatory Info :
Dosage : Pre-Filled Syringe
Dosage Strength :
Brand Name : JONEXA TROPHIC
Approval Date :
Application Number :
Registration Country : Italy
Regulatory Info :
Registration Country : Spain
Brand Name : SCULTUR REFORT
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Dosage :
Dosage Strength :
Brand Name : SCULTUR REFORT
Approval Date :
Application Number :
Registration Country : Spain
Regulatory Info :
Registration Country : Argentina
Brand Name : Dropstar
Dosage Form : Ophthalmic Solution
Dosage Strength : 0.4%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Packaging :
Regulatory Info :
Dosage : Ophthalmic Solution
Dosage Strength : 0.4%
Brand Name : Dropstar
Approval Date :
Application Number :
Registration Country : Argentina
Regulatory Info :
Registration Country : Spain
Brand Name : Relive Dry eye
Dosage Form : Solution
Dosage Strength : 0.4%; 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Dosage : Solution
Dosage Strength : 0.4%; 1%
Brand Name : Relive Dry eye
Approval Date :
Application Number :
Registration Country : Spain
Regulatory Info :
Registration Country : Spain
Hyaluronic Acid; Glycerine; Carboxymethyl Cellulose
Brand Name : Relive Night
Dosage Form : Solution
Dosage Strength : 0.4%; 1%; 0.5%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Hyaluronic Acid; Glycerine; Carboxymethyl Cellulose
Dosage : Solution
Dosage Strength : 0.4%; 1%; 0.5%
Brand Name : Relive Night
Approval Date :
Application Number :
Registration Country : Spain
Regulatory Info :
Registration Country : Spain
Brand Name : Hyaluronic-7 Serum
Dosage Form : Serum
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Dosage : Serum
Dosage Strength :
Brand Name : Hyaluronic-7 Serum
Approval Date :
Application Number :
Registration Country : Spain
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Pre-Filled Syringe
Dosage Strength : 32MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Pre-Filled Syringe
Dosage Strength : 32MG/2ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Endo-Ease
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging :
Regulatory Info : Generic
Dosage :
Dosage Strength :
Brand Name : Endo-Ease
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Protad
Dosage Form : INJECTION
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging :
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength :
Brand Name : Protad
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Greece
Hyaluronic Acid; Polyethylene Glycol; Oleic Acid; Sorbitol solutions; sodium dehydroacetate; Methyl parahydroxybenzoate; Lactic Acid
Brand Name : JALPLAST®
Dosage Form : Cream
Dosage Strength : 0.2%; 70%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Packaging :
Regulatory Info :
Hyaluronic Acid; Polyethylene Glycol; Oleic Acid; Sorbitol solutions; sodium dehydroacetate; Methyl parahydroxybenzoate; Lactic Acid
Dosage : Cream
Dosage Strength : 0.2%; 70%
Brand Name : JALPLAST®
Approval Date :
Application Number :
Registration Country : Greece
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Dosage Form : Tablet
Grade : Not Available
Brand Name : Disintequik™ MCC 25
Application : Co-Processed Excipients
Excipient Details : Direct Tabletting Operations Where Fast Disintegration Is Required
Dosage Form : Tablet
Grade : Not Available
Application : Co-Processed Excipients
Excipient Details : Orally Disintegrating Tablets
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
51
PharmaCompass offers a list of Hyaluronic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hyaluronic Acid manufacturer or Hyaluronic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hyaluronic Acid manufacturer or Hyaluronic Acid supplier.
PharmaCompass also assists you with knowing the Hyaluronic Acid API Price utilized in the formulation of products. Hyaluronic Acid API Price is not always fixed or binding as the Hyaluronic Acid Price is obtained through a variety of data sources. The Hyaluronic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hyaluronic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyaluronic Acid, including repackagers and relabelers. The FDA regulates Hyaluronic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyaluronic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hyaluronic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hyaluronic Acid supplier is an individual or a company that provides Hyaluronic Acid active pharmaceutical ingredient (API) or Hyaluronic Acid finished formulations upon request. The Hyaluronic Acid suppliers may include Hyaluronic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Hyaluronic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hyaluronic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Hyaluronic Acid active pharmaceutical ingredient (API) in detail. Different forms of Hyaluronic Acid DMFs exist exist since differing nations have different regulations, such as Hyaluronic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hyaluronic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Hyaluronic Acid USDMF includes data on Hyaluronic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hyaluronic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hyaluronic Acid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Hyaluronic Acid Drug Master File in Japan (Hyaluronic Acid JDMF) empowers Hyaluronic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Hyaluronic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of Hyaluronic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Hyaluronic Acid suppliers with JDMF on PharmaCompass.
Hyaluronic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hyaluronic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hyaluronic Acid GMP manufacturer or Hyaluronic Acid GMP API supplier for your needs.
A Hyaluronic Acid CoA (Certificate of Analysis) is a formal document that attests to Hyaluronic Acid's compliance with Hyaluronic Acid specifications and serves as a tool for batch-level quality control.
Hyaluronic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Hyaluronic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hyaluronic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Hyaluronic Acid EP), Hyaluronic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hyaluronic Acid USP).